Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Jun;109(2):405–410. doi: 10.1111/j.1476-5381.1993.tb13583.x

Interaction between the effects of 5-hydroxytryptamine and adrenaline on the growth of platelet thrombi in the coronary artery of the anaesthetized dog.

S J McAuliffe 1, H M Snow 1, B Cox 1, C C Smith 1, M I Noble 1
PMCID: PMC2175684  PMID: 8358542

Abstract

1. The interaction between adrenaline and 5-hydroxytryptamine (5-HT) has been quantitated on the rate of thrombus formation, in the stenosed coronary artery with damaged endothelium of the anaesthetized dog. 2. Changes in the plasma concentration of adrenaline were produced by varying the rate of an intravenous infusion of adrenaline and in the effects of 5-HT, by intravenous injections of the selective 5-HT2 receptor antagonist, ICI 170809. 3. Increases in the plasma concentration of adrenaline, which did not cause significant changes in blood pressure and heart rate, increased the rate of thrombus formation. 4. Antagonism of the 5-HT2 receptor by ICI 170809, in the absence of an infusion of adrenaline, abolished thrombus formation (mean ED50 0.41 microgram kg-1, i.v.). 5. The effects of adrenaline were non-competitively antagonized by ICI 170809; maximum effects were obtained in the dose-range 50-200 micrograms kg-1, i.v., when the mean dose-ratio increase in adrenaline required to restore equivalent rates of thrombus formation was 39 fold. 6. These results are consistent with a synergism between adrenaline and 5-HT and emphasize the importance of both on thrombus formation.

Full text

PDF
405

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashton J. H., Benedict C. R., Fitzgerald C., Raheja S., Taylor A., Campbell W. B., Buja L. M., Willerson J. T. Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries. Circulation. 1986 Mar;73(3):572–578. doi: 10.1161/01.cir.73.3.572. [DOI] [PubMed] [Google Scholar]
  2. Ashton J. H., Golino P., McNatt J. M., Buja L. M., Willerson J. T. Serotonin S2 and thromboxane A2-prostaglandin H2 receptor blockade provide protection against epinephrine-induced cyclic flow variations in severely narrowed canine coronary arteries. J Am Coll Cardiol. 1989 Mar 1;13(3):755–763. doi: 10.1016/0735-1097(89)90622-0. [DOI] [PubMed] [Google Scholar]
  3. De Clerck F. F., Herman A. G. 5-hydroxytryptamine and platelet aggregation. Fed Proc. 1983 Feb;42(2):228–232. [PubMed] [Google Scholar]
  4. De Clerck F., Xhonneux B., Leysen J., Janssen P. A. Evidence for functional 5-HT2 receptor sites on human blood platelets. Biochem Pharmacol. 1984 Sep 1;33(17):2807–2811. doi: 10.1016/0006-2952(84)90699-3. [DOI] [PubMed] [Google Scholar]
  5. De Clerck F., Xhonneux B., de Chaffoy de Courcelles D. Functional expression of the amplification reaction between serotonin and epinephrine on platelets. J Cardiovasc Pharmacol. 1988;11 (Suppl 1):S1–S5. [PubMed] [Google Scholar]
  6. Eichhorn E. J., Grayburn P. A., Willard J. E., Anderson H. V., Bedotto J. B., Carry M., Kahn J. K., Willerson J. T. Spontaneous alterations in coronary blood flow velocity before and after coronary angioplasty in patients with severe angina. J Am Coll Cardiol. 1991 Jan;17(1):43–52. doi: 10.1016/0735-1097(91)90702-b. [DOI] [PubMed] [Google Scholar]
  7. Fetkovska N., Fedelesova V., Dzurik R. Low-density lipoprotein amplifies the platelet response to serotonin in human plasma. J Hypertens Suppl. 1989 Dec;7(6):S164–S165. doi: 10.1097/00004872-198900076-00078. [DOI] [PubMed] [Google Scholar]
  8. Folts J. D., Crowell E. B., Jr, Rowe G. G. Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation. 1976 Sep;54(3):365–370. doi: 10.1161/01.cir.54.3.365. [DOI] [PubMed] [Google Scholar]
  9. Grant J. A., Scrutton M. C. Novel alpha2-adrenoreceptors primarily responsible for inducing human platelet aggregation. Nature. 1979 Feb 22;277(5698):659–661. doi: 10.1038/277659a0. [DOI] [PubMed] [Google Scholar]
  10. Haerem J. W. Platelet aggregates in intramyocardial vessels of patients dying suddenly and unexpectedly of coronary artery disease. Atherosclerosis. 1972 Mar-Apr;15(2):199–213. doi: 10.1016/0021-9150(72)90070-6. [DOI] [PubMed] [Google Scholar]
  11. Orlandi C., Humphrey W. R., Hollenberg N. K., Schaub R. G. In vivo demonstration of enhanced arterial constrictor response to serotonin following focal endothelial cell loss. Exp Mol Pathol. 1990 Apr;52(2):192–201. doi: 10.1016/0014-4800(90)90004-w. [DOI] [PubMed] [Google Scholar]
  12. Petty A. C., Scrutton M. C. Platelet aggregation in whole blood: is the response to adrenaline, 5-hydroxytryptamine and PAF a direct consequence of stimulation by these agonists? Thromb Res. 1989 Apr 15;54(2):151–159. doi: 10.1016/0049-3848(89)90045-5. [DOI] [PubMed] [Google Scholar]
  13. ROBERTSON J. I., ANDREWS T. M. Free serotonin in human plasma. Quantitative and qualitative estimation. Lancet. 1961 Mar 18;1(7177):578–580. doi: 10.1016/s0140-6736(61)92248-6. [DOI] [PubMed] [Google Scholar]
  14. Smith C. C., Betteridge J. Improved liquid-chromatographic determination of catecholamines in platelets. Clin Chem. 1984 Aug;30(8):1432–1433. [PubMed] [Google Scholar]
  15. Smith C. C., Curtis L. D., Delamothe A. P., Prichard B. N., Betteridge D. J. The distribution of catecholamines between platelets and plasma in normal human subjects. Clin Sci (Lond) 1985 Jul;69(1):1–6. doi: 10.1042/cs0690001. [DOI] [PubMed] [Google Scholar]
  16. Torr S., Noble M. I., Folts J. D. Inhibition of acute platelet thrombosis formation in stenosed canine coronary arteries by specific serotonin 5HT2 receptor antagonist ritanserin. Cardiovasc Res. 1990 Jun;24(6):465–470. doi: 10.1093/cvr/24.6.465. [DOI] [PubMed] [Google Scholar]
  17. Yao S. K., Rosolowsky M., Anderson H. V., Golino P., NcNatt J. M., De Clerck F., Buja L. M., Willerson J. T. Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations. J Am Coll Cardiol. 1990 Sep;16(3):705–713. doi: 10.1016/0735-1097(90)90363-t. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES